ProstaGorx
Natural health product licensed in Canada
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80085717
- Status
- Inactive licence
- Licence date
- 30 May 2018
- Revision date
- 17 August 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 210 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5.01 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Glycinate de sélénium | 70 mcg | 210 µg |
| D-saccharate de calcium Source : Saccharate de calcium | 1 mg | Not calculated |
| Rubus idaeus Source : Fruit | 25 mg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 100 mcg | 300 µg |
| Uncaria tomentosa Source : Écorce de racine Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 45 mg Potency : 3 % Oxindole alkaloids | 15 mg | Not calculated |
| Brassica oleracea var. italica Source : Fleur Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 40 mg | 10 mg | Not calculated |
| Acide L-glutamique Source : Acide glutamique | 10 mg | Not calculated |
| Agathosma betulina Source : Feuille | 5 mg | Not calculated |
| Grifola frondosa Source : En entier | 5 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 6.7 mg AT | Not calculated |
| Stérols végétaux libres Source : Stérols végétaux libres Potency : 45 % beta-Sitosterol | Not specified | Not calculated |
| Stérols végétaux libres Source : Arachis hypogaea (Whole) Potency : 45 % beta-Sitosterol | Not specified | Not calculated |
| Stérols végétaux libres Source : Stérols végétaux libres Potency : 27 % Campesterol | Not specified | Not calculated |
| Stérols végétaux libres Source : Arachis hypogaea (Whole) Potency : 27 % Campesterol | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 75 % Catechins | Not specified | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille | 5 mg | Not calculated |
| L-alanine Source : L-Alanine | 10 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral | 5 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Quercétine dihydraté | 5 mg | Not calculated |
| Althaea officinalis Source : Racine | 4 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 10 UI | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.67 mg | 5,010 µg |
| Zinc Source : Oxyde de zinc | 5 mg | 15,000 µg |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Stérols végétaux libres Source : Stérols végétaux libres Potency : 19 % Stigmasterol | 150 mg | Not calculated |
| Stérols végétaux libres Source : Arachis hypogaea (Whole) Potency : 19 % Stigmasterol | 150 mg | Not calculated |
| Annona muricata Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 75 mg Potency : 45 % Epigallocatechin 3-gallate | 25 mg | Not calculated |
| Solanum lycopersicum Source : Fruit Potency : 10 % Lycopene | 22 mg | Not calculated |
| Urtica dioica Source : Racine | 100 mg | Not calculated |
| Ganoderma lucidum Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 mg | 5 mg | Not calculated |
| Lentinula edodes Source : En entier | 5 mg | Not calculated |
| Juniperus communis Source : Fruit | 5 mg | Not calculated |
| Acide aminoacétique Source : Glycine | 5 mg | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine | 2 mg | Not calculated |
| Arctium lappa Source : Racine | 2 mg | Not calculated |
| Capsicum annuum Source : Fruit | 1 mg | Not calculated |
| Eupatorium purpureum Source : Racine | 4 mg | Not calculated |
| Petroselinum crispum Source : Sommité | 8 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, farine de riz, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Saw palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Helps to support prostate health. Stinging Nettle is used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps support urinary tract health by helping to relieve symptoms associated with benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085717
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging